{reportSlug=global-familial-adenomatous-polyposis-treatment-market, reportId=80321, mktKeyword=Familial Adenomatous Polyposis Treatment, cagr=0.00, publishDate=Jan 2024, priceOption2=6800, reportTitle=Familial Adenomatous Polyposis Treatment Comprehensive Study by Type (Icosapent, Eflornithine Hydrochloride, Aspirin, CEQ-508, Others), Application (Clinic, Hospital, Others), Familial Adenomatous Polyposis Type (Gardner syndrome, Turcot syndrome, Attenuated FAP, Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)), Treatment (Surgery to Remove Polyps or Growths, Chemotherapy, Radiation, Medications, Investigational Therapies) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=180, priceOption1=3750, forecastYr=2030, noOfPages=243, reportKey=79919, breadcrum=Global Familial Adenomatous Polyposis Treatment}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jan 2024 243 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner